| 23/05/17 | 08:00:15 | 23 May 2017 | | Bydureon EXSCEL trial meets T2D safety objective | RNS |
| 22/05/17 | 08:00:10 | 22 May 2017 | | AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE | RNS |
| 16/05/17 | 16:00:02 | 16 May 2017 | | Director/PDMR Shareholding | RNS |
| 12/05/17 | 08:00:08 | 12 May 2017 | | IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER | RNS |
| 10/05/17 | 08:00:10 | 10 May 2017 | | AZ updates on tralokinumab trial in severe asthma | RNS |
| 02/05/17 | 15:00:04 | 2 May 2017 | | Total Voting Rights | RNS |
| 02/05/17 | 08:00:13 | 2 May 2017 | | DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL | RNS |
| 27/04/17 | 18:30:03 | 27 Apr 2017 | | Result of AGM | RNS |
| 27/04/17 | 08:00:12 | 27 Apr 2017 | | AstraZeneca: Q1 2017 Results | RNS |
| 25/04/17 | 14:30:01 | 25 Apr 2017 | | TAGRISSO RECEIVES FULL APPROVAL IN THE EU | RNS |
| 03/04/17 | 16:00:02 | 3 Apr 2017 | | Total Voting Rights | RNS |
| 31/03/17 | 08:01:05 | 31 Mar 2017 | | Tagrisso (osimertinib) receives FDA full approval | RNS |
| 31/03/17 | 08:00:11 | 31 Mar 2017 | | AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICS | RNS |
| 28/03/17 | 17:00:02 | 28 Mar 2017 | | Director/PDMR Shareholding | RNS |
| 27/03/17 | 16:00:04 | 27 Mar 2017 | | Director/PDMR Shareholding | RNS |
| 17/03/17 | 07:00:08 | 17 Mar 2017 | | US FDA issues CRL for ZS-9 in hyperkalaemia | RNS |
| 16/03/17 | 11:00:01 | 16 Mar 2017 | | Notice of AGM | RNS |
| 15/03/17 | 07:00:11 | 15 Mar 2017 | | LYNPARZA PFS IN BRCA OVARIAN MAINTENANCE THERAPY | RNS |
| 08/03/17 | 07:00:09 | 8 Mar 2017 | | Filing of Form 20-F with SEC | RNS |
| 07/03/17 | 14:30:03 | 7 Mar 2017 | | Annual Financial Report | RNS |
| 06/03/17 | 07:00:10 | 6 Mar 2017 | | Directorate Change | RNS |
| 03/03/17 | 07:00:08 | 3 Mar 2017 | | ALLIANCE WITH SANOFI PASTEUR FOR MEDI8897 | RNS |
| 01/03/17 | 16:30:03 | 1 Mar 2017 | | Total Voting Rights | RNS |
| 28/02/17 | 07:02:40 | 28 Feb 2017 | | FDA approves once-daily Qtern for type-2 diabetes | RNS |
| 24/02/17 | 12:32:23 | 24 Feb 2017 | | CHMP positive opinion for ZS-9 in hyperkalaemia | RNS |
| 20/02/17 | 07:00:11 | 20 Feb 2017 | | AZ licenses Zoladex to TerSera for the US & Canada | RNS |
| 17/02/17 | 07:00:06 | 17 Feb 2017 | | Lynparza positive in metastatic BRCA breast cancer | RNS |
| 16/02/17 | 12:01:01 | 16 Feb 2017 | | SILIQ (BRODALUMAB) APPROVED BY US FDA | RNS |
| 02/02/17 | 07:00:08 | 2 Feb 2017 | | AZN: FY16 and Q4 2016 Results | RNS |
| 23/12/16 | 07:00:05 | 23 Dec 2016 | | AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS | RNS |
| 16/12/16 | 13:00:02 | 16 Dec 2016 | | Director/PDMR Shareholding | RNS |
| 09/12/16 | 15:05:42 | 9 Dec 2016 | | FDA accepts durvalumab for BLA in bladder cancer | RNS |
| 06/12/16 | 09:30:11 | 6 Dec 2016 | | Tagrisso data shows superiority over chemotherapy | RNS |
| 05/12/16 | 07:00:14 | 5 Dec 2016 | | AZ completes agreement for Rhinocort Aqua rights | RNS |
| 01/12/16 | 16:00:02 | 1 Dec 2016 | | Block listing Interim Review | RNS |
| 01/12/16 | 15:00:02 | 1 Dec 2016 | | Total Voting Rights | RNS |
| 22/11/16 | 07:00:12 | 22 Nov 2016 | | AZ head and neck cancer trials resume enrolment | RNS |
| 17/11/16 | 07:00:11 | 17 Nov 2016 | | AZ out-licensing deal with Allergan completed | RNS |
| 10/11/16 | 07:04:30 | 10 Nov 2016 | | Year-To-Date and Q3 2016 Results | RNS |
| 09/11/16 | 07:00:10 | 9 Nov 2016 | | Directorate Change | RNS |
| 01/11/16 | 15:30:02 | 1 Nov 2016 | | Dealing by Person Closely Associated | RNS |
| 01/11/16 | 15:00:02 | 1 Nov 2016 | | Total Voting Rights | RNS |
| 31/10/16 | 13:47:46 | 31 Oct 2016 | | AZ completes US Aralez agreement for Toprol-XL | RNS |
| 27/10/16 | 17:51:26 | 27 Oct 2016 | | AstraZeneca Head and Neck Cancer Trials | RNS |
| 26/10/16 | 08:00:05 | 26 Oct 2016 | | Positive results in AstraZeneca Lynparza trial | RNS |
| 18/10/16 | 08:00:10 | 18 Oct 2016 | | FDA accepts for review ZS-9 NDA for hyperkalaemia | RNS |
| 07/10/16 | 08:00:08 | 7 Oct 2016 | | AZ DIVESTS RIGHTS TO RHINOCORT AQUA OUTSIDE US | RNS |
| 04/10/16 | 08:05:02 | 4 Oct 2016 | | AZ agreement with Aralez for Toprol-XL in US | RNS |
| 04/10/16 | 08:00:05 | 4 Oct 2016 | | AstraZeneca reports top-line EUCLID results in PAD | RNS |
| 03/10/16 | 16:00:01 | 3 Oct 2016 | | Total Voting Rights | RNS |
